Gimv

Gimv is a European investment company with over 30 years of experience in private equity and venture capital. Based in Antwerp, Belgium, Gimv manages approximately 1.8 billion EUR in investments across 85 portfolio companies, which collectively generate over 6 billion EUR in revenue and employ more than 28,000 people. The firm focuses on identifying and supporting entrepreneurial and innovative companies with high-growth potential, aiming to transform them into market leaders. Gimv operates through four main investment platforms: Consumer 2020, Health & Care, Smart Industries, and Sustainable Cities. Each platform is supported by a dedicated team and leverages an extensive international network of experts. Additionally, Gimv has a specific venture capital fund targeting the software sector in the Czech Republic, emphasizing investment in medium-sized and large growth companies.

Jelle Assink

Associate

Guillame Bardy

Partner

Guillaume Bardy

Partner

Ronald Bartel

Partner

Ferdinand Becker

Associate

Patrick Van Beneden

Partner

Koen Bouckaert

Managing Partner

Nicolas De Bruyne

Principal

Kristof Vande Capelle

CFO

Anne Caron

Partner

Rishabh Chawla

Associate

Koen Dejonckheere

CEO

Dirk Dewals

Managing Partner and Head Connected Consumer

Bart Diels

Managing Partner

Patrick Franken

Partner

Thomas Goudriaan

Associate

Philipp von Hammerstein

Partner

Thomas Harth

Associate

Lisa Hengerer

Principal

Mathieu Himpe

Principal

von den Hoff, Maximilian

Associate

Arie Hooimeijer

Partner

Florian Hötzl

Associate

Dirk Jonkman

Associate

Andreas Jurgeit

Partner

Maxence Kasper

Principal

Hidde Van Kerckhoven

Associate

Gert Kerkstoel

Partner

Kevin Klein

Principal

Christoph Kocher

Associate

Elderd Land

Partner & Head of Gimv the Netherlands, Healthcare

Frank De Leenheer

Investor Relations and Corporate Communications Manager

Gautier Lefebvre

Partner

Erik Mampaey

Managing Partner

Guy Mampaey

Partner

Maja Markovic

Partner

Stéphanie Massart

Associate

Nick Medaer

Partner

Ruben Monballieu

Partner

Eric de Montgolfier

Partner and Head of Gimv France

Sven Oleownik

Partner and Head of Germany

David De Peuter

Principal

Hadrien Pigot

Associate

Rombout Poos

Partner

Morgane Renault

Associate

François-Xavier Rico

Associate

Clémence Robles

Principal

Emmanuel Sabonnadière

Partner

Nicolas de Saint-Laon

Partner and Head of GIMV France

Catharina Soenen

Principal

Charles Le Texier

Associate

Lars Timmer

Principal

Christophe Van Vaeck

Associate

Eric de La Vigne

Principal

Michaël Vlemmix

Principal

Tom Voorde

Managing Partner

Niklas Windmann

Associate

Boris Wirtz

Partner

Veldhuijzen van Zanten, Roland

Principal

Nicolas de Saint Laon

Partner and Head of Gimv France

Past deals in Belgium

Precirix

Series B in 2022
Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

Televic

Acquisition in 2020
Televic N.V. is a Belgium-based company that specializes in developing, manufacturing, and installing advanced communication products and solutions tailored for various sectors, including healthcare, education, railways, and conferencing. Founded in 1946, Televic offers a wide range of integrated audio-visual systems for settings such as conference rooms, auditoria, and control rooms, as well as on-board communication systems and passenger information solutions for the transportation industry. The company also provides digital networks for nurse call systems, intercoms, and patient entertainment. In education, Televic delivers innovative solutions, including digital and wireless language labs, virtualized learning environments, and classroom management software. With a commitment to high-tech quality, Televic aims to expand its global presence while maintaining a leading position in its specialized markets.

iSTAR Medical

Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Biotalys

Series C in 2019
Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Alro group

Acquisition in 2019
The Alro Group is a leading provider of coating services for the automotive industry, headquartered in Dilsen-Stokkem, Belgium. With a significant presence in Western and Central Europe, the company has evolved from a small operation into a reputable group specializing in various coating techniques. Alro Group offers a range of services including wet coating, electrocoating, powder coating, and assembly, allowing clients to obtain tailored metal and plastic products that meet their specific needs.

Precirix

Series A in 2018
Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

Impact

Acquisition in 2018
Impact is a temporary employment agency for specialists in technics, construction and office work. IMPACT is a specialized temporary employment agency with its headquarters in Hasselt. Their main objective? By means of a personal approach, a clear focus, and a great deal of engagement and expertise, they aim to match employers with specialists who are looking for a job in the fields of technics, construction, or office work. Thus, they contribute to the successful growth of enterprises and to the professional satisfaction of the experts who found a job thanks to them.

Cegeka

Venture Round in 2017
Cegeka is a European IT services provider based in Hasselt, Belgium, specializing in ICT solutions, services, and consulting. Established in 1986, the company has developed a comprehensive portfolio that includes end-to-end digital solutions, enterprise cloud services, cybersecurity, IT infrastructure monitoring, and ERP, APS, and CRM solutions. Cegeka also offers data intelligence and ICT outsourcing services. The company operates in ten European countries and employs over 5,000 people. It has grown significantly through both organic development and strategic acquisitions, solidifying its position as a key player in the European market. Founded originally as Tema Studio Informatica, Cegeka became a Microsoft solution provider in Italy by 1992 and has since expanded its offerings through various acquisitions, including the purchase of Brain Force and INDIS Italia. André Knaepen, the founder, led the company until 2019, when Stijn Bijnens took over as CEO.

Biotalys

Series B in 2017
Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Itineris

Venture Round in 2017
Itineris NV is a technology company specializing in customer care and operational solutions for the energy and water sectors in Europe and North America. Established in 2003 and headquartered in Sint-Martens-Latem, Belgium, Itineris develops UMAX, a multi-commodity business solution designed for both regulated and deregulated markets, addressing utilities such as electricity, gas, water, and telecom. The company offers a range of services, including consultancy, implementation, project-based support, and long-term application management. Itineris also provides expertise in business process transformation, customer relationship management, and reporting solutions. As a Microsoft Gold Partner, Itineris leverages Microsoft’s ERP platform to enhance its offerings. The company maintains additional offices in Georgia and Maryland, and has formed strategic partnerships with industry leaders like Microsoft, IBM, and Capgemini.
Riaktr is a Belgian scale-up founded in 2009 and backed by first class investors (Fortino, Endeit, GIMV). We started as a service company under the name ‘Real Impact Analytics’. At the time, Big Data was the new big thing, driving important corporate investments. Yet, too often such investments were not yielding the desired returns. Since day one, we pursue a clear mission: leverage the value of telecom data. We do this by starting from the field to build user-centric frameworks driving results. We resist the ‘black box’ principle by putting data at the service of human intelligence and bringing teams together under a collaborative approach. Our brand Riaktr, adopted in 2018, symbolizes our pivot from a services business to a product company. Today our software products address two major questions faced by telcos: - How can I optimize my network CAPEX investments? - How can I optimize my Sales & Distribution operations? Behind the scenes, we are a team of computer scientists, engineers and business consultants based in the heart of Brussels, with a local presence close to our clients in South-Africa and Brazil. We have worked in many countries in Africa, Latin America, the Caribbean and Europe. We work with six of the ten biggest telecom groups to revolutionize the telecom and Consumer Goods industries.

Contraload

Private Equity Round in 2016
Contraload is a fast growing Pan European company in pooling and rental services for plastic pallets and bins. For more than 10 years CLD has been focusing on plastic load carriers and has close to 1 million assets in its pool, all constantly on the move within the whole of Europe. CLD has a broad range of plastic pallets and IBCs for many different supply chains. Focus lies on the more complex food and FMCG supply chains with demanding and challenging global customers like Unilever, Nestle, Intersnack and many others. CLD helps its customers to meet the high quality and hygienic requirements, avoid foreign body contamination and to connect to suppliers or customers in a cost effective way. “CLD helps you carry the load”, so you can focus on your core business.

Itho Daalderop

Acquisition in 2016
Itho Daalderop B.V. is a manufacturer and supplier of heating, domestic hot water, ventilation, and control technology solutions for residential and business clients in the Netherlands and abroad. Founded in 1919 and based in Schiedam, with additional locations in Etten-Leur, Tiel, the United Kingdom, and Sint-Niklaas, Belgium, the company offers a range of products including boilers, heat pumps, solar water heaters, ventilation systems, and air purification devices. Itho Daalderop also serves as an advisory partner for various stakeholders, including governments, corporations, and construction firms, across new construction, renovation, and replacement projects. As a subsidiary of Klimaatgarant B.V. since 2016, the company is committed to providing energy-efficient solutions that promote a healthy and comfortable indoor climate.

CoScale

Venture Round in 2015
CoScale NV provides software solutions for IT operations analytics. It offers integrated platform to monitor full stack of containerized applications. It also provides COSCALE Application Performance Analyzer software that gathers and correlates data from Web applications and the underlying infrastructure to automatically identify and isolate disruptions, inefficiencies, and failures in Web applications; and enable organizations to optimize its infrastructure. The company offers its product as a subscription and licensing model for organizations operating in areas, such as e-commerce, online banking, online customer service, etc. CoScale NV was founded in 2013 and is based in Ghent, Belgium.

Itineris

Venture Round in 2015
Itineris NV is a technology company specializing in customer care and operational solutions for the energy and water sectors in Europe and North America. Established in 2003 and headquartered in Sint-Martens-Latem, Belgium, Itineris develops UMAX, a multi-commodity business solution designed for both regulated and deregulated markets, addressing utilities such as electricity, gas, water, and telecom. The company offers a range of services, including consultancy, implementation, project-based support, and long-term application management. Itineris also provides expertise in business process transformation, customer relationship management, and reporting solutions. As a Microsoft Gold Partner, Itineris leverages Microsoft’s ERP platform to enhance its offerings. The company maintains additional offices in Georgia and Maryland, and has formed strategic partnerships with industry leaders like Microsoft, IBM, and Capgemini.

EcoChem International

Acquisition in 2014
EcoChem develops and formulates eco-friendly flame retardants additives, which are mainly used in building & construction, transportation and electronic applications. The company’s products are added to materials such as wood, insulation, textiles or plastics in order to inhibit, suppress or delay flame and smoke production caused by fire. Headquartered in Olen (Belgium), EcoChem operates 2 production facilities located in Willlebroek (Belgium) and in Offenbach (Germany) and is serving clients in 25 countries.

Ablynx

Grant in 2014
Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

NovoPolymers

Private Equity Round in 2013
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Complix

Series B in 2013
Complix NV is a biopharmaceutical company based in Diepenbeek, Belgium, with research facilities in Zwijnaarde, Belgium, and an office in Esch-sur-Alzette, Luxembourg. Founded in 2008, the company specializes in the discovery and development of Alphabodies, a novel class of protein therapeutics designed to target difficult disease sites, particularly in oncology and autoimmune diseases. These Alphabodies demonstrate high affinity for a variety of disease targets and possess unique stability and versatility, enabling non-injectable delivery methods. Complix aims to address challenging intracellular targets, thereby offering patients alternatives to traditional antibodies and small molecules, with the intent of improving treatment outcomes for complex conditions such as cancer, autoimmune disorders, and viral diseases.

Luciad

Acquisition in 2013
Luciad provides high performance software tools for rapid application development of advanced systems. Our applications simplify the lives of developers and end users with advanced visual analytics that allow them to unlock the potential of real time location intelligence and create the foundations for next generation geospatial systems. From safeguarding critical assets to creating the digital infrastructure for smart cities, we help users implement intuitive command and control systems. Our customers depend on Luciad for high performance visualization that allows them to implement scalable solutions.

Lampiris

Venture Round in 2013
Lampiris, an independent supplier of gas, green power and energy services such as insulation, furnace maintenance, wood and pellets for heating, and smart thermostats, has been active in the Belgian energy market since 2005. Lampiris, which currently supplies more than a million accounts, is the third-largest supplier in the residential energy market in Belgium.

Multiplicom

Venture Round in 2013
Multiplicom N.V. is a Belgian company specializing in the development of molecular diagnostic test kits aimed at gathering genetic information for personalized treatment. Founded in 2010 and headquartered in Niel, Belgium, with an additional office in Lyon, France, the company provides a range of diagnostic assays across human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiac disorders, such as various BRCA assays and tests for conditions like Marfan syndrome and cystic fibrosis. In the oncology segment, Multiplicom offers assays for molecular tumor pathology and cancer genetics. The prenatal application features the Clarigo product, which screens for chromosome abnormalities. The company operates a MASTR facility in Niel and an informatics facility in Gent, Belgium. Since January 2017, Multiplicom has functioned as a subsidiary of Agilent Technologies, Inc.

Biotalys

Venture Round in 2013
Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

NovoPolymers

Venture Round in 2012
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

GreenWatt

Venture Round in 2012
GreenWatt is an established CleanTech company offering full engineering services, covering feasibility study conception, construction and starting up of turn key small scale biogas plants around innovative and unique patented technologies solving all key issues of anaerobic digestion.

Pronota

Series C in 2012
Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

VCST Industrial Products

Acquisition in 2011
VCST is a world-class automotive supplier of precision-machined powertrain and brake components for Automotive OEM’s and Tier 1 suppliers. The company realized a turnover of 169 million euro in 2015 and employs 1250 full time employees. VCST has production facilities in Belgium, China, Germany, Mexico and Romania, with its headquarters located in Belgium.

Trustteam

Private Equity Round in 2011
Trustteam NV is a provider of comprehensive information technology solutions for businesses, established in 2002 and headquartered in Kortrijk, Belgium, with additional locations in Heusden-Zolder and Paris. The company specializes in a range of services including cloud solutions, security, telephony, software, hardware, and IT consulting. Trustteam focuses on delivering outsourced IT management services that address various technology-related challenges faced by enterprises. By offering a complete suite of services, including security awareness training and digitization, Trustteam helps clients from diverse industries streamline their operations and concentrate on their core business activities, effectively alleviating their IT concerns.

XL Video

Venture Round in 2011
XL Video, an Ostend-belgim-based global player in the rental of video display systems for concerts, shows and other events. Founded in 1996 and led by CEO and co-founder René de Keijzer, XL Video is an international leading player in the rental of video technology, such as video screens, for major concert tours, trade fairs, TV shows, sports and other events. The group has a large stocks of high-end video technology such as video displays (LED, projection, plasma and LCD), HD camera systems and large trucks with built-in video screens. XL Video also develops and sells its own LED systems (Pixled).

Multiplicom

Venture Round in 2011
Multiplicom N.V. is a Belgian company specializing in the development of molecular diagnostic test kits aimed at gathering genetic information for personalized treatment. Founded in 2010 and headquartered in Niel, Belgium, with an additional office in Lyon, France, the company provides a range of diagnostic assays across human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiac disorders, such as various BRCA assays and tests for conditions like Marfan syndrome and cystic fibrosis. In the oncology segment, Multiplicom offers assays for molecular tumor pathology and cancer genetics. The prenatal application features the Clarigo product, which screens for chromosome abnormalities. The company operates a MASTR facility in Niel and an informatics facility in Gent, Belgium. Since January 2017, Multiplicom has functioned as a subsidiary of Agilent Technologies, Inc.

NovoPolymers

Series B in 2011
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Nomadesk

Series B in 2010
Nomadesk is a European SaaS company, founded in 2004 and focused on Business File Sharing & Synchronization technology.  We are leading developers of cloud software for sharing and synchronizing digital documents, allowing foremost business users to edit, share, synchronize and secure files from anywhere – online and offline! Our company maintains datacenter facilities in Europe (Frankfurt, Amsterdam) and USA (Asheville – NC) for our European and American customers, respectively. ​ Nomadesk mainly targets resellers, service providers and system integrators, who offer the Nomadesk solutions to their clients – usually under a proprietary name, or brand. ​ Nomadesk is part of UnifiedPost, an international BPaaS provider of integrated business process optimisation solutions including complete document delivery and processing solutions, complemented by payment, financial supply chain, credit management and secure e-identity solutions.

Private Outlet

Venture Round in 2010
Private Outlet SAS engages in the online retail of apparel for men, women, and children in France, Germany, Austria, Belgium, Spain, Ireland, Italy, Luxembourg, the Netherlands, Portugal, and the United Kingdom. It offers ready to wear clothing, footwear, accessories, fashion products, decoration products, jewelry, high-tech products, appliances, sports products, beauty products, house products, and lingerie for its members. The company was founded in 2006 and is based in Saint-Denis, France. Private Outlet SAS operates as a subsidiary of Andrino.

GreenPeak Technologies

Series B in 2009
GreenPeak Technologies BV, a fabless semiconductor/system company, develops ultra-low power wireless data communication controller chips for smart home applications and consumer electronics. It provides communication controller semiconductor products and software technologies for smart home data communications; a range of IEEE 802.15.4 and ZigBee silicon solutions; and Senior Lifestyle sensor and cloud based intelligent system technology to enable children and their elderly parents to privately and securely share lifestyle information. The company also offers integration, support, and training services. It markets and sells its products to OEMs and ODMs in the United States, Europe, Asia, and Latin-America. GreenPeak Technologies BV has a strategic partnership with Sensara. GreenPeak Technologies BV was formerly known as Xanadu Wireless BV and changed its name to GreenPeak Technologies BV in 2007. The company was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, China, France, the United States, Japan, and Korea. As of April 29, 2016, GreenPeak Technologies BV operates as a subsidiary of Qorvo, Inc.

Pronota

Series B in 2009
Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

NovoPolymers

Series A in 2009
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Luma International

Series A in 2009
Luma International was established in 2009 by a team of innovators, entrepreneurs and leading professionals in digital and personalized marketing. A successful mixture of knowledge and expertise. No matter how diverse the backgrounds of the founders and investors, they shared the same passion: innovation, with intelligent and effective communication as the objective. That objective took shape in Luma, an on-demand marketing platform for field and channel sales. It enables medium and large companies such as Toyota, Mercedes-Benz, Coca-Cola, Bacardi, P&V and others to create personalized marketing materials on-demand, which helps save money and drive sales. Using this solution, companies offer their sales and marketing organizations better support, enhance their marketing flexibility and improve the effectiveness of their campaigns, while still guaranteeing brand consistency. With Luma, marketing capitalizes fully on the sales organization's objectives. Because the needs to which Luma answers are not market or sector-related, companies from a variety of sectors have already implemented Luma successfully. Not only does Luma score well among users, but the platform has also garnered prestigious nominations and awards. The Luma platform’s capabilities reflect attributes of Marketing Resource Management, Enterprise 2.0 and Ecommerce 2.0. As the company continues to develop new capabilities, it pushes its technology further into these three areas. Today, Luma International has offices in Antwerp (Belgium), Rotterdam (The Netherlands), Paris (France) and Redwood Shores, CA (USA). For more information visit www.lumacentral.com.

Vandemoortele

Private Equity Round in 2009
Vandemoortele is a family-owned Belgian foods group with a European dimension. It manufactures and sells high-quality food products in two segments: frozen bakery products (Bakery Products) and margarines and fats (Lipids).

ActoGeniX

Private Equity Round in 2009
ActoGeniX is a biopharmaceutical company based in Zwijnaarde, Belgium, founded in 2006 by Bernard Coulie and Mark Vaeck. The company specializes in the development and commercialization of innovative biological drugs, utilizing a proprietary technology platform that leverages living non-pathogenic microorganisms for oral delivery of biopharmaceuticals. ActoGeniX aims to address unmet medical needs in gastrointestinal, immunological, and metabolic diseases, contributing to advancements in therapeutic options within these fields.

Clear2Pay

Venture Round in 2008
Clear2Pay is a payments technology company that specializes in delivering secure and efficient payment processing solutions for financial institutions. Its Open Payment Framework (OPF) is designed to enhance internal payment processing while offering clients faster payment services accompanied by comprehensive information. The OPF operates on a Service-Oriented Architecture (SOA), allowing institutions to process various payment types through a centralized payments engine that leverages a library of reusable business services. By enabling the integration of new service models with existing infrastructures, Clear2Pay helps banks protect their prior investments while facilitating a gradual transition to a more modern and efficient payments environment.

Viabuild

Private Equity Round in 2008
Viabuild Group N.V. provides road, civil, and drainage construction services. Viabuild Group N.V. was formerly known as Verhaeren Kembo Groep NV and changed its name to Viabuild Group N.V. in October, 2012. The company is based in Mechelen, Belgium. Viabuild Group N.V. operates as a subsidiary of NV Verhaeren & Co.

Diatos

Series D in 2007
Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).

Nomadesk

Series A in 2007
Nomadesk is a European SaaS company, founded in 2004 and focused on Business File Sharing & Synchronization technology.  We are leading developers of cloud software for sharing and synchronizing digital documents, allowing foremost business users to edit, share, synchronize and secure files from anywhere – online and offline! Our company maintains datacenter facilities in Europe (Frankfurt, Amsterdam) and USA (Asheville – NC) for our European and American customers, respectively. ​ Nomadesk mainly targets resellers, service providers and system integrators, who offer the Nomadesk solutions to their clients – usually under a proprietary name, or brand. ​ Nomadesk is part of UnifiedPost, an international BPaaS provider of integrated business process optimisation solutions including complete document delivery and processing solutions, complemented by payment, financial supply chain, credit management and secure e-identity solutions.

ActoGeniX

Venture Round in 2007
ActoGeniX is a biopharmaceutical company based in Zwijnaarde, Belgium, founded in 2006 by Bernard Coulie and Mark Vaeck. The company specializes in the development and commercialization of innovative biological drugs, utilizing a proprietary technology platform that leverages living non-pathogenic microorganisms for oral delivery of biopharmaceuticals. ActoGeniX aims to address unmet medical needs in gastrointestinal, immunological, and metabolic diseases, contributing to advancements in therapeutic options within these fields.

Movetis

Series A in 2007
Movetis NV, a pharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company's lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women. Resolor is also tested for chronic constipation in males and children, as well as opioid-induced constipation and post operative ileus. Its products also include M0002, which is in Phase II trials to treat ascites, an accumulation of fluid caused by liver malfunction; and M0003 that is entering Phase II development for symptomatic treatment of heartburn and regurgitation in patient's refractory to PPIs, and pediatric reflux. In addition, the company also has two prioritized compounds out of its preclinical portfolio, M0014 and M0012, and two compound libraries. It has partnership agreements with the universities of Ghent, Leuven, and Rotterdam. The company was founded in 2006 and is headquartered in Turnhout, Belgium.

Accent Jobs

Private Equity Round in 2006
ACCENT Jobs For People NV provides temporary employee recruitment and leasing services. It offers jobs in construction, engineering and production, sales and marketing, logistics and distribution, tourism, and other industries. The company was founded in 1995 and is based in Roeselare, Belgium.

Ablynx

Series C in 2006
Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

Pronota

Series A in 2006
Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

Clear2Pay

Series D in 2006
Clear2Pay is a payments technology company that specializes in delivering secure and efficient payment processing solutions for financial institutions. Its Open Payment Framework (OPF) is designed to enhance internal payment processing while offering clients faster payment services accompanied by comprehensive information. The OPF operates on a Service-Oriented Architecture (SOA), allowing institutions to process various payment types through a centralized payments engine that leverages a library of reusable business services. By enabling the integration of new service models with existing infrastructures, Clear2Pay helps banks protect their prior investments while facilitating a gradual transition to a more modern and efficient payments environment.

GreenPeak Technologies

Venture Round in 2006
GreenPeak Technologies BV, a fabless semiconductor/system company, develops ultra-low power wireless data communication controller chips for smart home applications and consumer electronics. It provides communication controller semiconductor products and software technologies for smart home data communications; a range of IEEE 802.15.4 and ZigBee silicon solutions; and Senior Lifestyle sensor and cloud based intelligent system technology to enable children and their elderly parents to privately and securely share lifestyle information. The company also offers integration, support, and training services. It markets and sells its products to OEMs and ODMs in the United States, Europe, Asia, and Latin-America. GreenPeak Technologies BV has a strategic partnership with Sensara. GreenPeak Technologies BV was formerly known as Xanadu Wireless BV and changed its name to GreenPeak Technologies BV in 2007. The company was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, China, France, the United States, Japan, and Korea. As of April 29, 2016, GreenPeak Technologies BV operates as a subsidiary of Qorvo, Inc.

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

Ablynx

Series B in 2004
Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

Ablynx

Series A in 2002
Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

ORMvision

Series B in 2001
Ormvision is a provider of relationship management systems to the telecom industry.